Article
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation - 1 Mar 2003
Fukasawa Mizuya, Matsushita Kazumichi, Kamiyama Manabu, Mikami Yuki, Araki Isao, Yamagata Zentaro, Takeda Masayuki
Abstract excerpt
BACKGROUND: Many reports indicate that a high homocysteine (Hcy) level is a potential risk factor for such thrombotic diseases as arteriosclerosis, myocardial infarction, and cerebral infarction in healthy individuals or hemodialysis (HD) patients. The methylentetrahydrofolate reductase (MTHFR) C677T polymorphism has been reported to be closely related to plasma Hcy level. METHODS: Using a cross-sectional design...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
